Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02051114 · ClinicalTrials.gov registry record
Discovering the Antecedents of Rheumatoid Arthritis Flare
A clinical trial of Rheumatoid Arthritis, sponsored by Rockefeller University.
- Active
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT02051114 is a study of Rheumatoid Arthritis that is active but no longer recruiting, run by Rockefeller University. The registered enrollment target is 25 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02051114, a study of Rheumatoid Arthritis, is active but no longer recruiting, sponsored by Rockefeller University.
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Longitudinal study of patients with rheumatoid arthritis comparing measures of disease activity with blood samples.
Conditions Studied
Study Locations (1)
New York
- The Rockefeller University Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-02 |
| Est. Completion | 2030-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02051114
The ClinicalTrials.gov registry entry for NCT02051114 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT02051114 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02051114 about?
NCT02051114 is a clinical study titled "Discovering the Antecedents of Rheumatoid Arthritis Flare". Longitudinal study of patients with rheumatoid arthritis comparing measures of disease activity with blood samples.
What is the current status of trial NCT02051114?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2014-02. Estimated completion is 2030-02.
What conditions does trial NCT02051114 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis.
Who is sponsoring clinical trial NCT02051114?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02051114 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.